These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1154 related items for PubMed ID: 27581457

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Muscarinic acetylcholine M4 receptors play a critical role in oxotremorine-induced DARPP-32 phosphorylation at threonine 75 in isolated medium spiny neurons.
    Liu L, Huang Y, Huang Q, Zhao Z, Yu J, Wang L.
    Neuropharmacology; 2017 May 01; 117():376-386. PubMed ID: 28257887
    [Abstract] [Full Text] [Related]

  • 6. Effects of Muscarinic Acetylcholine m1 and m4 Receptor Blockade on Dyskinesia in the Hemi-Parkinsonian Rat.
    Chambers NE, Meadows SM, Taylor A, Sheena E, Lanza K, Conti MM, Bishop C.
    Neuroscience; 2019 Jun 15; 409():180-194. PubMed ID: 31029732
    [Abstract] [Full Text] [Related]

  • 7. Alterations of M1 and M4 acetylcholine receptors in the genetically dystonic (dtsz) hamster and moderate antidystonic efficacy of M1 and M4 anticholinergics.
    Hamann M, Plank J, Richter F, Bode C, Smiljanic S, Creed M, Nobrega JN, Richter A.
    Neuroscience; 2017 Aug 15; 357():84-98. PubMed ID: 28596119
    [Abstract] [Full Text] [Related]

  • 8. The distinct role of medium spiny neurons and cholinergic interneurons in the D₂/A₂A receptor interaction in the striatum: implications for Parkinson's disease.
    Tozzi A, de Iure A, Di Filippo M, Tantucci M, Costa C, Borsini F, Ghiglieri V, Giampà C, Fusco FR, Picconi B, Calabresi P.
    J Neurosci; 2011 Feb 02; 31(5):1850-62. PubMed ID: 21289195
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Strength of cholinergic tone dictates the polarity of dopamine D2 receptor modulation of striatal cholinergic interneuron excitability in DYT1 dystonia.
    Scarduzio M, Zimmerman CN, Jaunarajs KL, Wang Q, Standaert DG, McMahon LL.
    Exp Neurol; 2017 Sep 02; 295():162-175. PubMed ID: 28587876
    [Abstract] [Full Text] [Related]

  • 15. Striatal cholinergic interneurons and D2 receptor-expressing GABAergic medium spiny neurons regulate tardive dyskinesia.
    Bordia T, Zhang D, Perez XA, Quik M.
    Exp Neurol; 2016 Dec 02; 286():32-39. PubMed ID: 27658674
    [Abstract] [Full Text] [Related]

  • 16. Chemogenetic modulation of cholinergic interneurons reveals their regulating role on the direct and indirect output pathways from the striatum.
    Aldrin-Kirk P, Heuer A, Rylander Ottosson D, Davidsson M, Mattsson B, Björklund T.
    Neurobiol Dis; 2018 Jan 02; 109(Pt A):148-162. PubMed ID: 29037828
    [Abstract] [Full Text] [Related]

  • 17. Striatal muscarinic receptors promote activity dependence of dopamine transmission via distinct receptor subtypes on cholinergic interneurons in ventral versus dorsal striatum.
    Threlfell S, Clements MA, Khodai T, Pienaar IS, Exley R, Wess J, Cragg SJ.
    J Neurosci; 2010 Mar 03; 30(9):3398-408. PubMed ID: 20203199
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 58.